(S1 (S (NP (NP (NP (NN Influence)) (PP (IN of) (NP (NN tetramerisation))) (PP (IN on) (NP (NP (JJ site-specific) (JJ post-translational) (NNS modifications)) (PP (IN of) (NP (NN p53)))))) (: :) (NP (NP (NN comparison)) (PP (IN of) (NP (ADJP (ADJP (JJ human)) (CC and) (ADJP (JJ murine))) (NN p53) (NN tumor) (NN suppressor) (NN protein)))) (. .))))
(S1 (S (S (NP (DT The) (NN tumor) (NN suppressor) (NN protein) (NN p53)) (VP (VBZ is) (VP (VP (VBN considered) (NP (NP (DT the) (`` ``) (NN Guardian)) (PP (IN of) (NP (DT the) (NN Genome) (POS ''))) (, ,) (ADJP (JJ crucial) (PP (IN for) (NP (NN cell) (NN cycle) (NN control)))))) (CC and) (VP (VBN mutated) (PP (IN in) (NP (NP (QP (IN over) (CD 50)) (NN %)) (PP (IN of) (NP (JJ human) (NNS cancers))))))))) (. .)))
(S1 (S (S (PP (VBG Following) (NP (JJ cellular) (NN stress))) (, ,) (NP (NP (JJ post-translational) (NNS modifications)) (PP (JJ such) (IN as) (NP (NP (NN phosphorylation)) (CC and) (NP (NN acetylation))))) (VP (VP (VB stabilise)) (CC and) (VP (VB activate) (NP (NN p53)) (PP (IN for) (NP (NP (NN cell) (NN cycle) (NN arrest)) (, ,) (NP (NN DNA) (NN repair)) (, ,) (NP (NN apoptosis)) (CC or) (NP (NN senescence))))))) (. .)))
(S1 (S (S (S (NP (NN p53) (NN protein)) (VP (VBZ functions) (PP (IN as) (NP (DT a) (NN tetramer))))) (CC and) (S (NP (PRP we)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NP (NN loss)) (PP (IN of) (NP (NN tetramerisation)))) (CC and) (NP (NP (NNS changes)) (PP (IN at) (NP (DT the) (NN N-terminus))))) (VP (VBP influence) (NP (NP (DT the) (NN recovery)) (PP (IN of) (NP (NP (JJ wild) (NN type) (NN p53)) (PRN (`` ') (NP (NN status)) ('' ')))))))))))) (. .)))
(S1 (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NN tetramerisation)) (CC and) (NP (JJ post-translational) (NNS modifications)))))))) (NP (PRP we)) (VP (VBD examined) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NP (JJ site-specific) (NNS modifications)) (PP (PP (IN in) (NP (NP (JJ wild) (NN type) (CC and) (JJ dimeric) (JJ mutant) (-LRB- -LRB-) (NN M340Q/L344R) (-RRB- -RRB-) (JJ murine) (NN p53)) (VP (VBN expressed) (PP (IN in) (NP (NN MEFs) (CD p53-LRB--/--RRB-)))))) (CC and) (PP (IN in) (NP (NP (JJ wild) (NN type)) (, ,) (NP (NP (ADJP (ADJP (ADJP (JJ monomeric)) (PRN (-LRB- -LRB-) (NP (NN L344P)) (-RRB- -RRB-))) (CC and) (ADJP (JJ dimeric))) (PRN (-LRB- -LRB-) (NP (NN M340Q/L344R)) (-RRB- -RRB-)) (JJ human) (NN p53)) (VP (VBN expressed) (PP (IN in) (NP (NN HCT116) (NN p53-LRB--/--RRB-) (NNS cells)))))))))))) (. .)))
(S1 (S (S (S (VP (VBG Using) (NP (JJ site-specific) (NNS antibodies)))) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (PP (IN in) (NP (JJ murine) (NN p53))) (, ,) (NP (NN S15)) (VP (VBZ is) (VP (VBN phosphorylated) (PP (IN in) (NP (DT a) (JJ tetramerisation-dependent) (NN manner))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (JJ human) (NN p53) (NN S15) (NN phosphorylation)) (VP (VBZ is) (RB not) (ADJP (JJ tetramerisation-dependent)))) (. .)))
(S1 (S (NP (NP (NN Inability)) (VP (TO to) (VP (VB form) (NP (NNS tetramers)) (PP (IN in) (NP (JJ human) (NN p53) (NNS proteins)))))) (VP (VBD reduced) (NP (NP (NP (JJ site-specific) (JJ N-terminal) (NN phosphorylation)) (PP (IN at) (NP (NP (NN S6)) (, ,) (NP (NN S9)) (CC and) (NP (NN S46))))) (CC and) (NP (NP (NP (VBN reduced) (JJ C-terminal) (NN phosphorylation)) (CC and) (NP (NN acetylation))) (PP (IN at) (NP (NP (NNP S315)) (CC and) (NP (NNP K382)))))) (ADVP (RB respectively))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN p53) (NN tetramerisation)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NP (NP (NP (JJ efficient) (NN p21)) (CC and) (NP (NN hdm2))) (NN transcription)) (CC and) (NP (NN protein) (NN expression))) (CC and) (NP (NP (NN recruitment)) (PP (IN of) (NP (NN p53))) (PP (TO to) (NP (NP (JJ specific) (NN promoter) (NNS regions)) (PP (IN of) (NP (NP (NN p21)) (CC and) (NP (NN hdm2)))))))))))) (. .)))
